Grading allergic ocular disease

Article

Research published online ahead of print by Graefe's Archive for Clinical and Experimental Ophthalmology, has revealed that allergic ocular diseases can be classified and clinically evaluated using a grading system.

Research published online ahead of print by Graefe's Archive for Clinical and Experimental Ophthalmology, has revealed that allergic ocular diseases can be classified and clinically evaluated using a grading system.

Eiichi Uchio and colleagues from Fukuoka University School of Medicine, Japan created a number of criteria for classifying and clinically evaluating the severity of allergic ocular diseases. They then evaluated the effectiveness of the criteria in the diagnosis of 1,079 patients.

The researchers diagnosed and classified allergic conjunctivitis, atopic keratoconjunctivitis and vernal keratoconjunctivitis based on local and systemic clinical findings. Ten objective conjunctival, limbal and corneal lesion findings were graded on a four-point scale. The total score was used as the clinical score, with a highest value of 30.

Of the 1,079 subjects, 876 (81.2%) were diagnosed with seasonal allergic conjunctivitis, 115 (10.7%) with perennial allergic conjunctivitis, 47 (4.4%) with atopic keratoconjunctivitis and 41 (3.8%) with vernal keratoconjunctivitis. The total clinical scores were 1.54 in seasonal allergic conjunctivitis, 2.13 in perennial allergic conjunctivitis, 3.72 in atopic keratoconjunctivitis and 12.68 in vernal keratoconjunctivitis.

The authors concluded that re-evaluation of allergic ocular disease is necessary for building future strategies for its treatment.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.